KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenon Pharmaceuticals (XENE) Net Margin: 2013-2025

Historic Net Margin for Xenon Pharmaceuticals (XENE) over the last 9 years, with Mar 2025 value amounting to -867.29%.

  • Xenon Pharmaceuticals' Net Margin was N/A to -867.29% in Q1 2025 from the same period last year, while for Mar 2025 it was -1,566.68%, marking a year-over-year change of. This contributed to the annual value of -1,324.32% for FY2022, which is 90621.00% down from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Net Margin stood at -867.29% for Q1 2025, which was up 96.92% from -28,143.94% recorded in Q3 2022.
  • Over the past 5 years, Xenon Pharmaceuticals' Net Margin peaked at -220.98% during Q1 2022, and registered a low of -28,143.94% during Q3 2022.
  • In the last 1 years, Xenon Pharmaceuticals' Net Margin had a median value of -867.29% in 2025 and averaged -867.29%.
  • Over the last 5 years, Xenon Pharmaceuticals' Net Margin had its largest YoY gain of 13,104bps in 2022, and its largest YoY loss of 2,780,876bps in 2022.
  • Quarterly analysis of 3 years shows Xenon Pharmaceuticals' Net Margin stood at -671.05% in 2021, then plummeted by 2,780,876bps to -28,143.94% in 2022, then reached -867.29% in 2025.
  • Its Net Margin was -867.29% in Q1 2025, compared to -28,143.94% in Q3 2022 and -5,813.06% in Q2 2022.